Cargando…

Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein

In this preclinical two-dose mucosal immunization study, using a combination of S1 spike and nucleocapsid proteins with cationic (N3)/or anionic (L3) lipids were investigated using an intranasal delivery route. The study showed that nasal administration of low amounts of antigens/adjuvants induced a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sengupta, Anirban, Azharuddin, Mohammad, Cardona, Maria E., Devito, Claudia, von Castelmur, Eleanore, Wehlin, Anna, Pietras, Zuzanna, Sunnerhagen, Maria, Selegård, Robert, Aili, Daniel, Alamer, Ali, Hinkula, Jorma, Al-Otaibi, Noha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029453/ https://www.ncbi.nlm.nih.gov/pubmed/35455253 http://dx.doi.org/10.3390/vaccines10040504

Ejemplares similares

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021)

Plantaricin NC8 αβ rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes
por: Omer, Abubakr A. M., et al.
Publicado: (2022)

The Epitope Study on the SARS-CoV Nucleocapsid Protein
por: Li, Shuting, et al.
Publicado: (2003)

The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
por: Yu, Haiyun, et al.
Publicado: (2023)

Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats
por: Silva, Everidiene K. V. B., et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection
por: Delgado, Juan F., et al.
Publicado: (2022)

In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5
por: Hatakeyama, Dai, et al.
Publicado: (2021)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity
por: Lee, Eunok, et al.
Publicado: (2021)

Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity
por: López-Muñoz, Alberto Domingo, et al.
Publicado: (2021)

Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity
por: López-Muñoz, Alberto Domingo, et al.
Publicado: (2021)

Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity
por: López-Muñoz, Alberto Domingo, et al.
Publicado: (2022)

Biochemical characterization of SARS-CoV-2 nucleocapsid protein
por: Zeng, Weihong, et al.
Publicado: (2020)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

DNA Folding by the SARS-CoV-2 Nucleocapsid Protein
por: Choi, Youna N., et al.
Publicado: (2021)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization
por: Shi, Shu-Qun, et al.
Publicado: (2006)

A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response
por: Zhao, Yinghua, et al.
Publicado: (2021)

Immunized mice naturally process in silico-derived peptides from the nucleocapsid of SARS-CoV-2
por: Campos-Ruíz, Mario Aldair, et al.
Publicado: (2023)

Analysis of the mechanism by which BALB/c mice having prior immunization with nucleocapsid protein of SARS-CoV develop severe pneumonia after SARS-CoV infection
por: Yasui, Fumihiko, et al.
Publicado: (2010)

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
por: Yao, Zhixian, et al.
Publicado: (2020)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Performance of Elecsys Anti-SARS CoV-2 (Roche) and VIDAS Anti-SARS CoV-2 (Biomérieux) for SARS-CoV-2 Nucleocapsid and Spike Protein Antibody Detection
por: Inés, Riberi María, et al.
Publicado: (2022)

Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2
por: Parashar, Nidarshana Chaturvedi, et al.
Publicado: (2020)

Architecture and self‐assembly of the SARS‐CoV‐2 nucleocapsid protein
por: Ye, Qiaozhen, et al.
Publicado: (2020)

Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
por: Terry, James S., et al.
Publicado: (2020)

The SARS-CoV nucleocapsid protein: A protein with multifarious activities
por: Surjit, Milan, et al.
Publicado: (2008)

Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein
por: Ye, Qiaozhen, et al.
Publicado: (2020)

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus
por: Zheng, Xiaoqin, et al.
Publicado: (2021)

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2022)

Plasticity in structure and assembly of SARS-CoV-2 nucleocapsid protein
por: Zhao, Huaying, et al.
Publicado: (2022)

Corrigendum to “Biochemical characterization of SARS-CoV-2 nucleocapsid protein”
por: Zeng, Weihong, et al.
Publicado: (2022)

The utility of SARS‐CoV‐2 nucleocapsid protein in laboratory diagnosis
por: Li, Xinwei, et al.
Publicado: (2022)

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2022)

Measuring DNA folding by the SARS-CoV-2 nucleocapsid protein
por: Kim, Jake J., et al.
Publicado: (2023)

Single-molecule spectroscopy of the SARS-CoV-2 nucleocapsid protein
por: Cubuk, Jasmine, et al.
Publicado: (2023)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

Adaptive immunity to SARS-CoV-2
por: Altmann, Daniel M
Publicado: (2020)

T cell immunity to SARS-CoV-2
por: Niessl, Julia, et al.
Publicado: (2021)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu, Tong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eblv93abekpgci9lukr9q70ohn